Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBMs Should Establish Standard Rx Benefit Card, Pharmacy Groups Say

Executive Summary

Pharmacy benefit management companies need to establish use of an industry-wide standard pharmacy benefit card, according to a "White Paper" issued Aug. 25 by three national pharmacy groups.

You may also be interested in...



Rx Prior Authorization Guidelines By Pharmacy/PBM Group Expected In March

Prescription drug prior authorization guidelines are expected to be finalized by a joint pharmacy/PBM task force in early March

Rx Prior Authorization Guidelines By Pharmacy/PBM Group Expected In March

Prescription drug prior authorization guidelines are expected to be finalized by a joint pharmacy/PBM task force in early March

Rx benefit card proposal

Model legislation calling for use of a uniform prescription benefit card is being distributed by the National Association of Chain Drug Stores, the American Pharmaceutical Association and the National Community Pharmacists Association to heads of state retail associations and state boards of pharmacy. An August 1999 "White Paper" co-written by the three associations calls for pharmacy benefit management organizations to establish use of an industry-wide standard pharmacy benefit card based on the standard card format laid out by the National Council for Prescription Drug Programs. The format calls for nine mandatory fields and three optional fields, and is presently voluntary in almost all states (1"The Pink Sheet" Aug. 30, p. 13)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel